• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Glaxo Wellcome S.p.A. 19-Sep-00 - DETAIL

Letter Issue Date Company Name Issuing Office Subject
09/19/2000 Glaxo Wellcome, S.p.A. Center for Drug Evaluation and Research Current Good Manufacturing Practices for Sterile Pharmaceuticals
Persons with disabilities having problems accessing the above pdf file may call 301-827-6567 for assistance